 |
Bernadette Toner is editorial director for GenomeWeb's premium content. E-mail Bernadette Toner or follow her GenomeWeb Twitter account at @GenomeWeb. |
In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM
October 02, 2012
In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - Researchers Rank MiSeq over PGM for Usability; Expect Their Sequencing Output to Grow by Half in 2013
January 22, 2013 / In Sequence - Survey Finds MiSeq, Ion PGM Tied for Most Likely Sequencing Purchase over Next 12 Months
April 24, 2012 / In Sequence - Sequencing Survey Finds Customers Happiest with HiSeq 2500
April 16, 2013 / In Sequence - BGI Reviews Next-Gen Sequencing Platforms, Highlighting Advantages of Each System
August 14, 2012 / In Sequence